Global Perspectives
In this book, a worldwide panel of leading experts discuss the role of inflammation in the pathogenesis of major chronic diseases and the current controversy regarding risk versus benefit of selective cyclooxygenase-2 (COX-2) inhibitors. The autho...
The revelation that aspirin and aspirin-like compounds have notableantineo plastic properties has revolutionized cancer research. COX-2 Blockade in Cancer Prevention and Therapy chronicles the evidence and presents exciting new op portunities for ...
Education M.D., University of Nebraska 1983 Ph.D., Genetics, North Carolina State University 1974 M.S., Genetics, University of Nebraska 1971 Board Certifications: Clinical Pathology, Public Health Research Epidemiological studies of selective and non-selective cyclooxygenase-2 (COX-2) inhibitors and cancer. Books COX-2 Blockade in Cancer Prevention and Therapy (2002). Humana Press: New York, NY. Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy (2007). Springer: New York, NY. Dr. Harris has written 135 peer reviewed scientific articles, numerous book chapters, and edited two major textbooks on the role of inflammation in the etiopathogenesis of cancer and other chronic diseases. His research shows that inhibition of the inducible cyclooxygenase-2 (COX-2) gene has powerful anti-neoplastic effects against major forms of cancer. In recognition of this work, he was elected a Fellow of the American Association for the Advancement of Science by his peers.